NCT04096430

Brief Summary

Children with disabilities often access rehabilitation services to improve their abilities to participate in everyday activities. Goal-directed therapy is considered an important therapeutic strategy to achieve outcomes that are meaningful to families. Not a lot is known about the effects of goal setting on rehabilitation outcomes. Strategies to help children participate in the goal-setting process are rarely used in clinical practice. The aim of this project is to test the effects of a child-focussed goal setting approach, Enhancing Child Engagement in Goal Setting (ENGAGE), on therapy outcomes. Service use and the cost vs. benefits of the ENGAGE approach compared to usual practice will also be examined. Children with neurodevelopmental disabilities aged 5-12 years old (n=96) who access paediatric rehabilitation services at six rehabilitation sites will participate. Therapists (n=24) at participating sites in Alberta, Canada will be randomized into 1) the ENGAGE intervention group or 2) the usual therapy practice control group. Children will participate in the ENGAGE approach to goal setting or usual practice based on the allocation of their therapist. This study will determine if the ENGAGE approach to goal setting affects child goal performance, satisfaction with goal performance, functional abilities, participation, and parent and child quality of life. The investigators will also evaluate differences in parent and child quality of life in relation to parent costs (e.g., absenteeism, presenteeism, travel costs) and compare amount of therapy time between the two groups to see which approach is more cost-effective and efficient. After the study, children, parents and therapists will be asked to discuss aspects that influenced effective implementation of the ENGAGE approach. This study could provide evidence to improve meaningful child and family outcomes in paediatric rehabilitation and improve efficiency of paediatric rehabilitation services.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Mar 2022May 2026

First Submitted

Initial submission to the registry

August 14, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 19, 2019

Completed
2.4 years until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Last Updated

January 6, 2026

Status Verified

December 1, 2025

Enrollment Period

4.3 years

First QC Date

August 14, 2019

Last Update Submit

December 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Goal performance and satisfaction will be measured using the Canadian Occupational Performance Measure (COPM).

    Change in the COPM will be examined between baseline (pre-treatment) and post-treatment (within 10 days of completing therapy), and post-treatment (within 10 days of completing therapy) and 3-months post-treatment. The COPM is an interview style measure in which a child is asked by an assessor to identify goal areas and then rate their current level on a 1 to 10 scale as far as importance, satisfaction and performance. A higher score represents a more favorable outcome.

    1) baseline (pre-treatment), 2) post-treatment (within 10 days of completing therapy), and 3) at 3-months post-treatment

Secondary Outcomes (7)

  • Child engagement in therapy will be measured using the Pediatric Rehabilitation Intervention Measure of Engagement (PRIME-SP).

    1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment

  • Perceived confidence will be measured using the Belief in Goal Self-Competence Scale [BiGSS].

    1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment

  • Goal related performance will be measured using the Goal Attainment Scaling (GAS).

    1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment

  • Participation for young children will be measured using the Participation and Environment Measure for Children & Youth (PEM-CY).

    1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment

  • Quality of life for children will be measured using the KIDSCREEN-27.

    1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment

  • +2 more secondary outcomes

Study Arms (2)

ENGAGE approach (child-oriented goal-setting)

EXPERIMENTAL

Therapists will receive training on our principles-based goal setting approach and strategies in the goal setting toolbox. Training will include an overview of tools and strategies including the Perceived Efficacy and Goal Setting Tool (PEGS) and the Pediatric Activity Card Sort (PACS). In addition, we will provide training on Goal Attainment Scaling and administration of the Canadian Occupational Performance Measure (COPM). We will introduce simple strategies to assist children in identifying goals and to ensure ongoing focus on goals using principles of motivational interviewing, strategies to assess and nurture perceived competence (self-efficacy), and child-friendly feedback strategies on goal-related performance.

Behavioral: ENGAGE approach (child-oriented goal-setting)

Usual care

NO INTERVENTION

The control group will comprise of usual care.

Interventions

See description of experimental arm.

ENGAGE approach (child-oriented goal-setting)

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • are between the ages of 5-12 years
  • are able to engage in the goal-setting process (determined by therapists)
  • are referred to PT and/or OT for a period of direct treatment
  • speak English.
  • Children will be excluded from the trial if:
  • the parent or guardian who attends therapy does not speak English
  • the child has a diagnosis that suggests developmental regression
  • the child has uncontrolled seizures (i.e., seizure within the past 2 months).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Renfrew Educational Services

Calgary, Alberta, T2E 6S5, Canada

RECRUITING

Society for Treatment of Autism

Calgary, Alberta, T2J 0E8, Canada

RECRUITING

Children's Rehabilitation Services, Alberta Health Services

Camrose, Alberta, Canada

RECRUITING

Centre for Autism Services Alberta

Edmonton, Alberta, T6E 5H5, Canada

RECRUITING

Children's Rehabilitation Services, Alberta Health Services

Grande Prairie, Alberta, Canada

RECRUITING

Children's Rehabilitation Services, Alberta Health Services

Red Deer, Alberta, Canada

RECRUITING

MeSH Terms

Conditions

Autism Spectrum DisorderNeurodevelopmental DisordersCerebral Palsy

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveMental DisordersBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Lesley Pritchard-Wiart, PhD

    University of Alberta, Faculty of Rehabilitation Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lesley Pritchard-Wiart, PhD

CONTACT

Sandy Thompson-Hodgetts, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Trained assessors, blinded to group allocation, will complete the measures with families. Family members will be blinded to all initial responses on the measures.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: We will use a pragmatic, cluster randomized controlled trial (RCT) design with therapists randomized to one of two groups; the ENGAGE intervention group or the usual care control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2019

First Posted

September 19, 2019

Study Start

March 1, 2022

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2026

Last Updated

January 6, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations